Objectives: To compare hematological parameters between deletional and nondeletional HbH diseases, and to investigate the correlation between HbH levels and hematological parameters within these 2 groups.
Southeast Asian (SEA) type deletion accounted for 98% of the samples with HbH disease and α-thalassemia-1 Thai type deletion made up the rest. A 3.7 kb deletion accounted for 91% of α-thalassemia-2, and a 4.2 kb deletion made up the rest of the deletional HbH disease, while the Hb CS variant was the majority of the nondeletional HbH disease. 3 The genetic heterogeneity study in 213 Thai pediatric patients with nondeletional HbH disease showed 51.00%, 6.48%, 0.84%, and 0.56% of compound heterozygosity for α-thalassemia-1 SEA type deletion with Hb CS (-- 2 Both of Hb PNP and Hb QS are highly unstable and undetectable by routine Hb electrophoresis, 4, 5 while Hb CS and Hb PS can be detected by capillary electrophoresis (CE) and are presented at zone (Z) 2 of the CE electropherogram. 6 Thus, the DNA analysis for detection of α-thalassemia-1, Hb CS, and Hb PS is recommended to be performed in cases that have peaks of Hb Bart, HbH, and
Hb CS/Hb PS on CE electropherogram (Figure 1) , whereas those for detection of α-thalassemia-1 and α-thalassemia-2 (3.7 and 4.2 kb deletions), Hb PNP, Hb QS, or other α-globin variants are recommended to be performed in cases that have peaks of Hb Bart and HbH ( Figure 1 ).
Several studies have demonstrated the correlation between hematological, biochemical, and clinical features with α-globin genotypes in different populations of HbH diseases. 2, 3, 7, 8 The aims of this study are to compare the hematological parameters between the deletional and nondeletional HbH diseases, and to investigate the correlation between the HbH or Hb Bart levels and hematological parameters within these two groups.
Materials and Methods
This retrospective study was conducted at the Associated Medical Sciences Clinical Service Center (AMS-CSC) at Chiang Mai University, Chiang Mai, Thailand. The hematological data of samples tested from September 2015 to February 2017 with HbH disease were selected for the study. Their complete blood counts (CBCs) were analyzed by an automated blood counter (NIHON KOHDEN MEK-8222K, Tokyo, Japan). The Hb analysis was performed using CE (Capillary 2 Flex Piercing, Sebia, Norcross, GA). The molecular diagnosis for α-thalassemia-1 (SEA and Thai type deletions) was detected by using the real-time polymerase chain reaction (PCR) with SYBR Green1 and high resolution melting analysis. 9 The α-thalassemia-2 (3.7 and 4.2 kb deletions) was detected by using the conventional Gap-PCR. 10 In addition, the multiplex asymmetric allele-specific PCR was performed for diagnosis of Hb CS and Hb PS as previously described. 11 The samples that had combination of HbH disease and hemoglobinopathy or β-thalassemia, and received blood transfusion within a month of hemoglobin analysis were excluded from the study.
Statistical Analysis
The data were presented as mean and standard deviation (SD). Statistical analyses were performed using SPSS software package (Statistical Package for the Social Sciences 11.0, Chicago, IL). Mean levels of hematological parameters were compared between the 2 groups of deletional and nondeletional HbH diseases using compare means with independent samples t-test. The correlations between the HbH
Figure 1
Diagram showing the workflow for analysis of genetic heterogeneity of deletional and nondeletional HbH diseases.
or Hb Bart levels and hematological parameters within these two groups were also analyzed by using Pearson correlation. The P value < .05 was considered statistically significant.
Results
From September 2015 to February 2017, the 15,652 blood samples were submitted to the AMS-CSC for the thalassemia diagnosis. The deletional and nondeletional HbH diseases were diagnosed in 358 (2.29%) and 100 (0.64%), respectively. By following the exclusion criteria, a total of 65 samples, including 43 deletional and 22 nondeletional HbH diseases, were used in the study. Among 43 samples with deletional HbH disease, 39 (90.7%) were compound heterozygosity for α-thalassemia-1 SEA type deletion and α-thalassemia-2 3.7 kb deletion (--
) while 4 (9.3%) samples, were compound heterozygosity for α-thalassemia-1 SEA type deletion and α-thalassemia-2 4. The characteristics and hematological data within the 2 groups of deletional and nondeletional HbH diseases are shown in Table 1 . There were no statistical differences in mean age and gender between the 2 groups of samples. The RBC counts, total Hb, PCV, MCHC, HbA, and HbA 2 of deletional HbH disease were significantly higher than those of nondeletional HbH disease. On the other hand, the mean corpuscular volume (MCV), MCH, Hb Bart, HbH, and HbF of the former were significantly lower than those of the latter. In both groups of deletional and nondeletional HbH diseases, there were no correlation between Hb Bart levels and assessed hematological parameters (RBC counts, total Hb, PCV, MCV, MCH, and MCHC). A negative correlation between HbH and RBC counts, and a positive correlation between HbH and MCV and MCH were detected in the group of deletional HbH disease (Figures 2A, 2D , and 2E respectively), whereas a positive correlation between HbH and RBC counts, total Hb, and PCV was found in the group of nondeletional HbH disease ( Figures 2F, 2G , and 2H respectively).
Discussion
HbH disease shows a wide spectrum of clinical phenotypes, ranging from asymptomatic to severe forms, requiring occasional or even regular transfusion, exceptionally, to HbH hydrops fetalis syndrome. 3, 12 The clinical variability 
Figure 2
Correlations between HbH levels and hematological parameters (RBC counts, total Hb, PCV, MCV, and MCH) within the group of deletional HbH disease (A-E, respectively) and nondeletional HbH disease (F-J, respectively).
depends on a considerable genetic heterogeneity. In this study, we compared the hematological parameters between the deletional and nondeletional HbH diseases and also investigated the correlation between the HbH or Hb Bart levels and hematological parameters within these 2 groups.
Of the 65 samples with HbH disease, 43 (66%) samples had the deletional genotype and 22 (34%) samples had the nondeletional genotype. In addition, the --SEA /-α 3.7 was the most common type (90.7%) of deletional HbH disease, whereas the --SEA /α cs α was the most common type (100%) of nondeletional HbH disease. These results were consistent with the previous studies in Thailand, 3 Hong Kong, 7, 13 Taiwan, 13 and Canada, 14 which showed an incidence of deletional HbH disease higher than that of nondeletional HbH disease. The most common genotype of deletional HbH disease was --
, while the nondeletional HbH disease was --SEA /α cs α. However, they were contrary with the previous study in pediatric patients with HbH disease living in northern Thailand, which showed a higher incidence of -- The RBC counts, and total Hb, PCV, MCHC, HbA, and HbA 2 of nondeletional HbH disease were lower than those of deletional HbH disease, whereas the MCV, MCH, Hb Bart, and HbH of the former were higher than those of the latter. The finding was consistent with the previous studies in Thailand, which showed newborns, children, and adolescents with deletional HbH disease had significantly higher RBC counts, and total Hb, PCV, MCHC, HbA, and HbA 2 , and had significantly lower levels of MCV, MCH, reticulocytes, Hb Bart, and HbH than those with nondeletional HbH disease. 3, 15 The study in California also revealed that newborns with nondeletional HbH disease had a higher Hb Bart than those with deletional HbH disease. 16 These results demonstrated that the nondeletional HbH disease showed more severe hemolytic anemia features than did the deletional HbH disease. The finding could be explained by a greater decrease in the α-globin chain synthesis in nondeletional HbH disease, and by the α 2 -globin gene normally controlling the synthesis of three-quarters of the α-globin chains, whereas the downstream α 1 -globin gene controls only one quarter. 17 Mutant forms of the α 2 -globin gene such as Hb CS, probably retain normal transcriptional activity, but there is no protein production. Transcription of the mutant α 2 -globin gene interferes with transcription of the normal α 1 -globin gene, resulting in reduced synthesis of normal α-globin chains. 18 Therefore, positive correlation between HbH and total Hb was observed in nondeletional HbH disease. In addition, the more hemolysis and severe anemia in nondeletional HbH disease induces the more of red blood cell production. That could be explained by the significantly positive correlation between HbH and RBC counts and PCV. In constrast with the deletional HbH disease, the transcription of a single α-globin gene can occur without interference. 3 Although there were significantly positive correlations between HbH and MCV and MCH, the negative correlation between HbH and RBC counts was observed in the deletional HbH disease. Therefore, it reflected that the HbH was diluted by HbA.
The limitation of this study was the missing data of red cell distribution width (RDW) and reticulocyte. Thus, the correlation between HbH and RDW or reticulocyte within the 2 groups of deletional and nondeletional HbH diseases cannot be analyzed.
In summary, the hematological alterations between Thai samples with deletional and nondeletional HbH diseases were different. The better understanding of hematological features in these samples is beneficial for the management planning, genetic counseling, treatment, and family education. LM
